Citation Impact
Citing Papers
Effect of secretin on release of heterogeneous forms of gastrin.
1975 StandoutNobel
Kinome-wide Functional Screen Identifies Role of PLK1 in Hormone-Independent, ER-Positive Breast Cancer
2014
Gastric cancer
2016 Standout
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
2005 StandoutNobel
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
The DNA-damage response in human biology and disease
2009 StandoutNature
Effect of RNA Silencing of Polo-Like Kinase-1 (PLK1) on Apoptosis and Spindle Formation in Human Cancer Cells
2002
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
Cell death by mitotic catastrophe: a molecular definition
2004
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
1998
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Oncogenes and tumour suppressors take on centrosomes
2007
A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non–Small-Cell Lung Cancer
2015
ESEA: Discovering the Dysregulated Pathways based on Edge Set Enrichment Analysis
2015
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
2005 StandoutNature
Genetic instabilities in human cancers
1998 StandoutNature
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
1998
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
2005
Polo-like kinases: a team that plays throughout mitosis
1998
β2-Adrenergic Receptor Lacking the Cyclic AMP-Dependent Protein Kinase Consensus Sites Fully Activates Extracellular Signal-Regulated Kinase 1/2 in Human Embryonic Kidney 293 Cells: Lack of Evidence for Gs/Gi Switching.
2002
HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression
2005 StandoutNobel
The Hallmarks of Cancer
2000 Standout
Characteristics of the Cholecystokinin-Induced Depolarization of Pacemaking Activity in Cultured Interstitial Cells of Cajal from Murine Small Intestine
2013 Standout
Telomere Dysfunction Increases Mutation Rate and Genomic Instability
2001 StandoutNobel
Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding
2009
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Telomere dysfunction and the initiation of genome instability
2003 StandoutNobel
Involvement of NADPH Oxidase Isoforms and Src Family Kinases in CD95-dependent Hepatocyte Apoptosis
2005
Cancer genes and the pathways they control
2004 Standout
Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers
2008 StandoutNobel
The Cyclin-Ubiquitin Ligase Activity of Cyclosome/APC Is Jointly Activated by Protein Kinases Cdk1-Cyclin B and Plk
2002 StandoutNobel
Mitotic kinases as regulators of cell division and its checkpoints
2001
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
2016 Standout
Expression of Polo-Like Kinase 1 (PLK1) Protein Predicts the Survival of Patients with Gastric Carcinoma
2006
Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation
2002 Standout
Chk2 Oligomerization Studied by Phosphopeptide Ligation
2008 StandoutNobel
Non-ATP competitive protein kinase inhibitors as anti-tumor therapeutics
2009
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
Polo-like kinases and the orchestration of cell division
2004
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Polo-like kinases: positive regulators of cell division from start to finish
1998
DNA replication and damage checkpoints and meiotic cell cycle controls in the fission and budding yeasts
2000 StandoutNobel
The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability
2001 StandoutNobel
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
Subcellular Distribution and Function of Rab3A-D in Pancreatic Acinar AR42J Cells
2001
Cell Cycle-regulated Phosphorylation of the XenopusPolo-like Kinase Plx1
2002
Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver
2003
Targeting polo-like kinase 1 for cancer therapy
2006
The Molecular Basis for Phosphodependent Substrate Targeting and Regulation of Plks by the Polo-Box Domain
2003
The Survivin-like C. elegans BIR-1 Protein Acts with the Aurora-like Kinase AIR-2 to Affect Chromosomes and the Spindle Midzone
2000 StandoutNobel
Agonist-specific Transactivation of Phosphoinositide 3-Kinase Signaling Pathway Mediated by the Dopamine D2 Receptor
2003
The cancer genome
2009 StandoutNature
Dosage‐dependent switch from G protein‐coupled to G protein‐independent signaling by a GPCR
2006 StandoutNobel
Localization Versus Function of Rab3 Proteins
2002 StandoutNobel
The Yeast Tor Signaling Pathway Is Involved in G2/M Transition via Polo-Kinase
2008 StandoutNobel
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Polo-Like Kinase 1 Is Essential for Early Embryonic Development and Tumor Suppression
2008
A novel mutant allele of the chromatin-bound fission yeast checkpoint protein Rad17 separates the DNA structure checkpoints
2000 StandoutNobel
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection
2002
Iterative in Situ Click Chemistry Assembles a Branched Capture Agent and Allosteric Inhibitor for Akt1
2011 StandoutNobel
The effects of somatostatin and metiamide on tachyphylaxis of pentagastrin stimulated gastric acid and pepsin secretion in the conscious cat.
1977 StandoutNobel
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome
2004 StandoutNobel
Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells
2006 StandoutNobel
Constitutive Expression of AID Leads to Tumorigenesis
2003 StandoutNobel
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
DNA Double-Strand Breaks
2002 StandoutNobel
Palladium‐Catalyzed Fluorosulfonylvinylation of Organic Iodides
2017 StandoutNobel
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Crosstalk between G-protein-coupled receptors and Epidermal growth factor receptor in cancer
2007
An open‐label, single‐arm, phase 2 trial of the polo‐like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer
2013
End Resection Initiates Genomic Instability in the Absence of Telomerase
2003 StandoutNobel
Works of Robert Elez being referenced
Pertussis Toxin Inhibits Cholecystokinin- and Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Activation by Disinhibition of the cAMP Signaling Pathway and Inhibition of c-Raf-1
2000
Cholecystokinin Stimulates Extracellular Signal-regulated Kinase through Activation of the Epidermal Growth Factor Receptor, Yes, and Protein Kinase C
2003
Interferon Alfa Down–Regulates Cd81 in Patients With Chronic Hepatitis C
2001
Tumor regression by combination antisense therapy against Plk1 and Bcl-2
2003
Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer
1997
Polo-like kinase1, a New Target for Antisense Tumor Therapy
2000
Cyclic AMP Induces Transactivation of the Receptors for Epidermal Growth Factor and Nerve Growth Factor, Thereby Modulating Activation of MAP Kinase, Akt, and Neurite Outgrowth in PC12 Cells
2002
Pertussis Toxin Inhibits Cholecystokinin- and Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Activation by Disinhibition of the cAMP Signaling Pathway and Inhibition of c-Raf-1
2000
Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck.
1999